{"doi":"10.2215/cjn.13601021","title":"Atrasentan: The Difficult Task of Integrating Endothelin A Receptor Antagonists into Current Treatment Paradigm for Diabetic Kidney Disease","abstract":null,"journal":"Clinical Journal of the American Society of Nephrology","year":2021,"id":609669,"datarank":0.31191623125197543,"base_score":2.0794415416798357,"endowment":2.0794415416798357,"self_citation_contribution":0.31191623125197543,"citation_network_contribution":0.0,"self_endowment_contribution":0.31191623125197543,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":7,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1567128,"name":"Beatriz Fernandez-Fernandez","orcid":null,"position":1,"is_corresponding":false},{"id":23179,"name":"Alberto Ortíz","orcid":"0000-0002-9805-9523","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Atrasentan: The Difficult Task of Integrating Endothelin A Receptor Antagonists into Current Treatment Paradigm for Diabetic Kidney Disease","abstract":"CKD will become the fifth global cause of death by 2040, and diabetes is the most common cause of CKD worldwide ([1][1]). This illustrates the global need for optimized early diagnosis and treatment of diabetic kidney disease (DKD). The long-term effect of recently approved kidney protective","is_dataset_classified":null,"base_score":2.0794415416798357,"endowment":2.0794415416798357,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"34853063","pmcid":"PMC8729503","openalex_id":"https://openalex.org/W3217347412","authors":[],"funders":[{"funder_name":"Instituto de Salud Carlos III","grant_id":"DTS18/00032","title":null},{"funder_name":"Instituto de Salud Carlos III","grant_id":"PI18/01366","title":null},{"funder_name":"Instituto de Salud Carlos III","grant_id":"PI19/00588","title":null},{"funder_name":"Instituto de Salud Carlos III","grant_id":"PI19/00815","title":null},{"funder_name":"Instituto de Salud Carlos III","grant_id":"PI20/00744","title":null},{"funder_name":"Instituto de Salud Carlos III","grant_id":"REDinREN RD016/0009","title":null},{"funder_name":"ERA-PerMed-JTC2018","grant_id":"KIDNEY ATTACK AC18/00064","title":null},{"funder_name":"ERA-PerMed-JTC2018","grant_id":"PERSTIGAN AC18/00071","title":null},{"funder_name":"Comunidad de Madrid","grant_id":"B2017/BMD-3686 CIFRA2-CM","title":null},{"funder_name":"FRIAT","grant_id":"","title":null},{"funder_name":"Sociedad Española de Nefrología","grant_id":"","title":null}],"total_grants":11,"fwci":0.5645,"citation_percentile":0.68951776,"influential_citations":0,"citation_trend":[{"year":2022,"count":2},{"year":2023,"count":1},{"year":2024,"count":1},{"year":2025,"count":3}],"oa_status":"green","license":null,"oa_locations":[{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8729503","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8729503","host_type":"repository"},{"url":"https://journals.lww.com/10.2215/CJN.13601021","host_type":"publisher"},{"url":"https://doi.org/10.2215/cjn.13601021","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/34853063","host_type":"repository"}],"fields_of_study":["Diabetes Treatment and Management","Pancreatic function and diabetes","Nitric Oxide and Endothelin Effects","Humans","Atrasentan","Endothelin A Receptor Antagonists","Diabetic Nephropathies","Albuminuria","Endothelin Receptor Antagonists","Pyrrolidines","Endothelin-1","Diabetes Mellitus"],"mesh_terms":["Atrasentan","Albuminuria","Diabetes Mellitus","Diabetic Nephropathies","Humans","Pyrrolidines","Endothelin-1","Endothelin Receptor Antagonists","Endothelin A Receptor Antagonists"],"keywords":["Kidney disease","Endothelin receptor","Diabetes mellitus","Disease","Kidney","Diabetic nephropathy","Receptor","Albuminuria","Atrasentan","Endothelin A Receptor Antagonists"],"sdg_mappings":[],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[{"name":"nct"}],"source":"live","citation_network_status":"fetched"},"created_at":"2026-07-31T12:48:52.376551Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}